Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
about
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug DevelopmentInhibition of FAAH confers increased stem cell migration via PPARαTwo Affinity Sites of the Cannabinoid Subtype 2 Receptor Identified by a Novel Homogeneous Binding Assay.[6]-Gingerol induces bone loss in ovary intact adult mice and augments osteoclast function via the transient receptor potential vanilloid 1 channel.
P2860
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@ast
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@en
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@nl
type
label
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@ast
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@en
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@nl
prefLabel
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@ast
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@en
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@nl
P2860
P921
P1476
Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.
@en
P2860
P304
P356
10.2174/157015910792246173
P577
2010-09-01T00:00:00Z